Long-term Safety of BCX9930 in Participants With Paroxysmal Nocturnal Hemoglobinuria

Clinical trial NCT05741346 · TERMINATED

Trial details

NCT number: NCT05741346
Sponsor: BioCryst Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Paroxysmal Nocturnal Hemoglobinuria

Start date: 2023-01-18
Primary completion: 2025-01-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.